Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors

被引：7

作者：

Deharo, Pierre ^{[1
,2
,3
]}

Pankert, Mathieu ^{[1
,2
,3
]}

Quilici, Jacques ^{[1
,2
,3
]}

Bonnet, Guillaume ^{[1
,2
,3
]}

Bassez, Clemence ^{[1
,3
]}

Verdier, Valentine ^{[5
]}

Morange, Pierre ^{[2
,3
,4
]}

Alessi, Marie-Christine ^{[2
,3
,4
]}

Bonnet, Jean-Louis ^{[1
,2
,3
]}

Cuisset, Thomas ^{[1
,2
,3
]}

机构：

[1] CHU Timone, Dept Cardiol, F-13385 Marseille, France

[2] INSERM, UMR1062, Nutr Obes & Risk Thrombosis, F-13385 Marseille, France

[3] Aix Marseille Univ, Fac Med, F-13385 Marseille, France

[4] CHU Timone, Lab Hematol, F-13385 Marseille, France

[5] Assistance Publ Hop Marseille, EMAI, Marseille, France

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2015年 / 184卷

关键词：

Chronic kidney disease; Platelet reactivity; P2Y12; blockers; Acute coronary syndromes; ACUTE CORONARY SYNDROMES; ANTIPLATELET THERAPY; CLOPIDOGREL; PRASUGREL; REACTIVITY; GUIDELINES;

D O I：

10.1016/j.ijcard.2015.02.077

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：428 / 430

页数：3

共 50 条

[31] Comparison of P2Y12 Inhibitors in Acute Coronary Syndromes in the Australian Population [J].

Hou, Mingxi ;

Hyun, Karice ;

Chew, Derek P. ;

Kritharides, Leonard ;

Amos, David ;

Brieger, David .

HEART LUNG AND CIRCULATION, 2022, 31 (08) :1085-1092

[32] Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue [J].

Schoener, Lisa ;

Jellinghaus, Stefanie ;

Richter, Bernhardt ;

Pfluecke, Christian ;

Ende, Georg ;

Christoph, Marian ;

Quick, Silvio ;

Loehn, Tobias ;

Speiser, Uwe ;

Poitz, David M. ;

Mierke, Johannes ;

Strasser, Ruth H. ;

Ibrahim, Karim .

CLINICAL RESEARCH IN CARDIOLOGY, 2017, 106 (11) :868-874

[33] Looking into the future of platelet transfusion in the presence of P2Y12 inhibitors [J].

Tanaka, K. A. ;

Subramaniam, K. .

BRITISH JOURNAL OF ANAESTHESIA, 2014, 112 (05) :780-784

[34] New P2Y12 antagonists [J].

Michelson, Alan D. .

CURRENT OPINION IN HEMATOLOGY, 2009, 16 (05) :371-377

[35] Novel Platelet ADP P2Y12 Inhibitors in the Treatment of Acute Coronary Syndrome [J].

Tan, Guang-Ming ;

Lam, Yat-Yin ;

Yan, Bryan P. .

CARDIOVASCULAR THERAPEUTICS, 2012, 30 (04) :e167-e173

[36] Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y12 inhibitors: Insights from the EUCLID trial [J].

Hsia, Judith ;

Kavanagh, Sarah T. ;

Hopley, Charles W. ;

Baumgartner, Iris ;

Berger, Jeffrey S. ;

Fowkes, Gerry R. ;

Jones, W. Schuyler ;

Mahaffey, Kenneth W. ;

Norgren, Lars ;

Patel, Manesh R. ;

Rockhold, Frank ;

Blomster, Juuso ;

Katona, Brian G. ;

Hiatt, William R. ;

Bonaca, Marc P. .

VASCULAR MEDICINE, 2021, 26 (06) :608-612

[37] Protease-activated receptor-mediated platelet aggregation in patients with type 2 diabetes on potent P2Y12 inhibitors [J].

Panzer, Benjamin ;

Wadowski, Patricia P. ;

Huber, Kurt ;

Panzer, Simon ;

Gremmel, Thomas .

DIABETIC MEDICINE, 2022, 39 (08)

[38] Platelet P2Y12 receptor inhibition by thienopyridines: status and future [J].

Porto, Italo ;

Giubilato, Simona ;

De Maria, Giovanni Luigi ;

Blasucci, Luigi Marzio ;

Crea, Filippo .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (09) :1317-1332

[39] P2Y12 Platelet Receptors: Importance in Percutaneous Coronary Intervention [J].

de Andrade Falcao, Felipe Jose ;

Carvalho, Leonardo ;

Chan, Mark ;

Rodrigues Alves, Claudia Maria ;

Camargo Carvalho, Antonio Carlos ;

Caixeta, Adriano Mendes .

ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 101 (03) :277-282

[40] Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists [J].

Becker, Richard C. .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (04) :513-514

← 1 2 3 4 5 →